45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
82,328
Insurances with rates
38
CPT / HCPCS codes
29,430
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 3088581 | IMPLANT NEURORECEIVER | $76,184 | $68,566 | — | — | 11 |
| 3088581 | IMPLANT NEURORECEIVER | $76,184 | $68,566 | — | — | 12 |
| 15170017 | Autologous cultured chondrocytes, implant | $74,720 | $67,248 | — | — | 11 |
| 15170017 | Autologous cultured chondrocytes, implant | $74,720 | $67,248 | — | — | 12 |
| 3088990 | BI-VENTRICULAR ICD ATLAS II | $73,456 | $66,111 | — | — | 11 |
| 3088990 | BI-VENTRICULAR ICD ATLAS II | $73,456 | $66,111 | — | — | 12 |
| 3088991 | BI-VENTRICULAR ICD ATLAS/EPIC | $66,347 | $59,713 | — | — | 11 |
| 3088991 | BI-VENTRICULAR ICD ATLAS/EPIC | $66,347 | $59,713 | — | — | 12 |
| 14593885 | 58468-0200-01 - alemtuzumab 10 mg/mL SOLN | $56,885 | $51,197 | — | — | 11 |
| 14593885 | 58468-0200-01 - alemtuzumab 10 mg/mL SOLN | $56,885 | $51,197 | — | — | 12 |
| 14564167 | INSERTION/RPLCMT PERIPHERAL/GASTRIC NPGR | $53,611 | $48,250 | — | — | 11 |
| 14564167 | INSERTION/RPLCMT PERIPHERAL/GASTRIC NPGR | $53,611 | $48,250 | — | — | 12 |
| 3089097 | DEFIBRILLATOR ATLAS II | $51,893 | $46,704 | — | — | 11 |
| 3089097 | DEFIBRILLATOR ATLAS II | $51,893 | $46,704 | — | — | 12 |
| 3089113 | DUAL CHAMBER ICD | $49,760 | $44,784 | — | — | 11 |
| 3089113 | DUAL CHAMBER ICD | $49,760 | $44,784 | — | — | 12 |
| 3089212 | INSERT/REMOVE AICD | $47,902 | $43,112 | — | — | 11 |
| 3089212 | INSERT/REMOVE AICD | $47,902 | $43,112 | — | — | 12 |
| 3089342 | SINGLE CHAMBER ICD | $47,391 | $42,652 | — | — | 11 |
| 3089342 | SINGLE CHAMBER ICD | $47,391 | $42,652 | — | — | 12 |
| 14632514 | 15054-1120-04 - lanreotide 120 mg/0.5 mL SOLN | $45,898 | $41,308 | — | — | 11 |
| 14632514 | 15054-1120-04 - lanreotide 120 mg/0.5 mL SOLN | $45,898 | $41,308 | — | — | 12 |
| 15221164 | 50242-0105-01 - polatuzumab vedotin 140 mg Powd | $44,667 | $40,201 | — | — | 11 |
| 15221164 | 50242-0105-01 - polatuzumab vedotin 140 mg Powd | $44,667 | $40,201 | — | — | 12 |
| 3088583 | IMPLANT SPINAL INFUSION PUMP | $44,186 | $39,767 | — | — | 11 |
| 3088583 | IMPLANT SPINAL INFUSION PUMP | $44,186 | $39,767 | — | — | 12 |
| 14458355 | 15054-1120-03 - lanreotide 120 mg/0.5 mL SOLN [F] | $43,920 | $39,528 | — | — | 11 |
| 14458355 | 15054-1120-03 - lanreotide 120 mg/0.5 mL SOLN [F] | $43,920 | $39,528 | — | — | 12 |
| 15131399 | 69097-0870-67 - lanreotide 120 mg/0.5 mL SOLN | $42,685 | $38,416 | — | — | 11 |
| 15131399 | 69097-0870-67 - lanreotide 120 mg/0.5 mL SOLN | $42,685 | $38,416 | — | — | 12 |
| 14580370 | 47335-0177-95 - tildrakizumab 100 mg/mL SOLN [F] | $39,400 | $35,460 | — | — | 11 |
| 14580370 | 47335-0177-95 - tildrakizumab 100 mg/mL SOLN [F] | $39,400 | $35,460 | — | — | 12 |
| 15147404 | Impella CP Pump Set | $37,835 | $34,052 | — | — | 11 |
| 15147404 | Impella CP Pump Set | $37,835 | $34,052 | — | — | 12 |
| 2870328 | GENERATOR PULSE IMPLANT 7427 | $37,146 | $33,431 | — | — | 11 |
| 2870328 | GENERATOR PULSE IMPLANT 7427 | $37,146 | $33,431 | — | — | 12 |
| 14609370 | WAVELINQ ENDOVASCULAR AVF CREATION | $35,357 | $31,821 | — | — | 11 |
| 14609370 | WAVELINQ ENDOVASCULAR AVF CREATION | $35,357 | $31,821 | — | — | 12 |
| 3089213 | INSERT/REPLACE PULSE GEN | $34,320 | $30,888 | — | — | 11 |
| 3089213 | INSERT/REPLACE PULSE GEN | $34,320 | $30,888 | — | — | 12 |
| 14609873 | Vertiflex Initial Level | $32,168 | $28,951 | — | — | 11 |
| 14634746 | DESTRUCTION OF INTRAOSSEOUS BASIVERTEBRAL NERVE, FIRST TWO BODIES INCLUDING FLOUROSCOPY | $32,168 | $28,951 | — | — | 11 |
| 14609873 | Vertiflex Initial Level | $32,168 | $28,951 | — | — | 12 |
| 14634746 | DESTRUCTION OF INTRAOSSEOUS BASIVERTEBRAL NERVE, FIRST TWO BODIES INCLUDING FLOUROSCOPY | $32,168 | $28,951 | — | — | 12 |
| 14564166 | INC IMPLTJ PERIPH NERVE NEUROSTIMULATOR ELTRD | $31,176 | $28,058 | — | — | 11 |
| 14564166 | INC IMPLTJ PERIPH NERVE NEUROSTIMULATOR ELTRD | $31,176 | $28,058 | — | — | 12 |
| 15163786 | Shockwave IVL w/Ather/Stent/PTA Lower Ext. | $30,000 | $27,000 | — | — | 11 |
| 15238942 | SFA POP STENT ATHERECTOMY [F] | $30,000 | $27,000 | — | — | 11 |
| 15238948 | TIBIAL PERONEAL STENT/ATHERECTOMY [F] | $30,000 | $27,000 | — | — | 11 |
| 15163786 | Shockwave IVL w/Ather/Stent/PTA Lower Ext. | $30,000 | $27,000 | — | — | 12 |
Showing top 50 of 82,328 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.